Spotlight
Memorials
Classifieds
Families First
VCAs
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
La Niña returns: Expect warmer winter with below-normal snowfall for Triangle in 25-26
Recommended
From the bus to the classroom: Former driver is NC's newest winner of prestigious teaching award
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Health & Science
CVS Health Corp
Eli Lilly and Co
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Madrigal Pharmaceuticals Inc
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
March 14, 2024
Tags
Novo Nordisk A/S
WW International Inc
Weight loss diets
From
CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
March 13, 2024
Tags
Investment strategy
Stock markets
Health care industry
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Biotechnology
Health & Science
US: News
From
CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
March 08, 2024
Tags
Mad Money
U/S/ Markets
Compagnie Financiere Richemont SA
From
CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
March 08, 2024
Tags
Novo Nordisk A/S
Business News
Breaking News: Business
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Business
Health & Science
Pharmaceuticals
From
CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
March 08, 2024
Tags
Novo Nordisk A/S
Markets
Europe Markets
From
CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
March 07, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
U/S/ Markets
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Eli Lilly and Co
US: News
Health & Science
From
CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
March 04, 2024
Tags
Business News
Novo Nordisk A/S
Investment Strategy
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Viking Therapeutics Inc
Companies
Business
From
CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
March 01, 2024
Tags
Europe Politics
UniCredit SpA
Deutsche Bank AG
From
CNBC.com News
5 things to know before the stock market opens Thursday
February 29, 2024
Tags
Politics
Investment strategy
Business
From
CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
February 29, 2024
Tags
World Markets
Economic events
Warner Bros Discovery Inc
From
CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
February 28, 2024
Tags
Warner Bros Discovery Inc
Asia Markets
Novo Nordisk A/S
From
CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
February 28, 2024
Tags
WW International Inc
Weight management
Diets and dieting
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
Health & Science
Zoetis Inc
Pets
From
CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
February 27, 2024
Tags
Eli Lilly and Co
Zealand Pharma A/S
Health & Science
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Breaking News: Markets
Health & Science
Household Products
From
CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
February 26, 2024
Tags
Novo Nordisk A/S
Markets
Zealand Pharma A/S
From
CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
February 16, 2024
Tags
Social issues
Employee healthcare benefits
Eli Lilly and Co
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Companies
Business
Pharmaceuticals
From
CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
February 06, 2024
Tags
US: News
Eli Lilly and Co
Health & Science
From
CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
February 05, 2024
Tags
Biotechnology
Mergers
Health & Science
From
CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
January 31, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Earnings
From
CNBC.com News
5 things to know before the stock market opens Monday
January 29, 2024
Tags
Advanced Micro Devices Inc
Meta Platforms Inc
Apple Inc
From
CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
Tags
Health & Science
Eli Lilly and Co
US: News
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Structure Therapeutics Inc
Breaking news
Business News
From
CNBC.com News
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.